Bank of America Downgrades Acadia Healthcare (NASDAQ:ACHC) to Neutral

Key Points

• Bank of America has downgraded Acadia Healthcare's stock from a "buy" to a "neutral" rating, with a price target set at $25.00.
• Acadia Healthcare recently reported earnings of $0.83 EPS for the quarter, outperforming analyst expectations of $0.71 EPS.
• The company has a consensus rating of "Moderate Buy" among analysts, with varying price targets ranging from $20.00 to $39.00.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was downgraded by Bank of America from a "buy" rating to a "neutral" rating in a note issued to investors on Wednesday, Marketbeat Ratings reports. They currently have a $25.00 price objective on the stock, down from their previous price objective of $27.00. Bank of America's target price would suggest a potential upside of 17.07% from the stock's previous close.

A number of other research analysts have also commented on ACHC. Royal Bank Of Canada dropped their price objective on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. UBS Group lowered their target price on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. Raymond James Financial restated an "outperform" rating and set a $26.00 price target (down previously from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Finally, KeyCorp lowered their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $39.00.

Acadia Healthcare Stock Performance

Shares of ACHC traded down $0.38 during midday trading on Wednesday, reaching $21.36. 868,043 shares of the stock were exchanged, compared to its average volume of 2,225,422. Acadia Healthcare has a twelve month low of $17.13 and a twelve month high of $79.82. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $1.97 billion, a price-to-earnings ratio of 14.12, a PEG ratio of 4.28 and a beta of 0.89. The business's 50-day moving average price is $22.09 and its 200 day moving average price is $24.06.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm's revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, sell-side analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Verdence Capital Advisors LLC boosted its position in Acadia Healthcare by 3.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company's stock worth $333,000 after purchasing an additional 465 shares during the period. EverSource Wealth Advisors LLC raised its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after purchasing an additional 497 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Acadia Healthcare by 10.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock worth $202,000 after acquiring an additional 622 shares during the last quarter. LPL Financial LLC increased its position in Acadia Healthcare by 1.2% in the first quarter. LPL Financial LLC now owns 56,527 shares of the company's stock worth $1,651,000 after buying an additional 697 shares during the period. Finally, Quantinno Capital Management LP increased its stake in shares of Acadia Healthcare by 9.0% in the fourth quarter. Quantinno Capital Management LP now owns 8,695 shares of the company's stock valued at $345,000 after purchasing an additional 721 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.